12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
5) Bosi A, Laszlo D, Labopin M et al. Second allogeneic bone marrow transplantation in acute leukemia:<br />
Results of a survey by the European Cooperative Group <strong>for</strong> Blood and Marrow Transplantation. Journal of<br />
Clinical Oncology. 2001;19:3675-3684.<br />
6) Michallet M, Tanguy ML, Socie G et al. Second allogeneic haematopoietic stem cell transplantation in<br />
relapsed acute and chronic leukaemias <strong>for</strong> patients who underwent a first allogeneic bone marrow<br />
transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM). British Journal of<br />
Haematology. 2000;108:400-407.<br />
7) Bosi A, Bacci S, Miniero R et al. Second allogeneic bone marrow transplantation in acute leukemia: A<br />
multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO). Leukemia. 1997;11:420-<br />
424.<br />
8) Chiang KY, Weisdorf DJ, Davies SM et al. Outcome of second bone marrow transplantation following a<br />
uni<strong>for</strong>m conditioning regimen as therapy <strong>for</strong> malignant relapse. Bone Marrow Transplantation. 1996;17:39-<br />
42.<br />
9) Duus JE, Stiff PJ, Choi J et al. Second allografts <strong>for</strong> relapsed hematologic malignancies: feasibility of using a<br />
different donor. Bone Marrow Transplantation. 2005;35:261-264.<br />
10) Hosing C, Saliba RM, Shahjahan M et al. Disease burden may identify patients more likely to benefit from<br />
second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia.<br />
Bone Marrow Transplantation. 2005;36:157-162.<br />
11) Calderwood S, Doyle JJ, Rolland-Grinton M et al. When are second allogeneic bone marrow transplants<br />
indicated in pediatric patients? International Journal of Pediatric Hematology/Oncology. 1998;5:337-343.<br />
12) Messori A, Bosi A, Bacci S et al. Retrospective survival analysis and cost-effectiveness evaluation of second<br />
allogeneic bone marrow transplantation in patients with acute leukemia. Bone Marrow Transplantation.<br />
1999;23:489-495.<br />
13) Radich JP, Gooley T, Sanders JE et al. Second allogeneic transplantation after failure of first autologous<br />
transplantation. Biology of Blood and Marrow Transplantation. 2000;6:272-279.<br />
14) Tomonari A, Iseki T, Ooi J et al. Second allogeneic hematopoietic stem cell transplantation <strong>for</strong> leukemia<br />
relapse after first allogeneic transplantation: Outcome of 16 patients in a single institution. International<br />
Journal of Hematology. 2002;75:318-323.<br />
15) Wagner JE, Vogelsang GB, Zehnbauer BA et al. Relapse of Leukemia After Bone-Marrow Transplantation<br />
- Effect of 2Nd Myeloablative Therapy. Bone Marrow Transplantation. 1992;9:205-209.<br />
110